3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Glioblastoma
115
Gliosarcoma
53
Brain Neoplasms
53
Glioma
47
Central Nervous System Neoplasms
30
Astrocytoma
29
Melanoma
26
Oligodendroglioma
14
Neuroblastoma
10
Neoplasm Metastasis
9
Recurrence
7
Ependymoma
7
Sarcoma
6
Neoplasms
6
Carcinoma, Non-Small-Cell Lung
6
Skin Neoplasms
5
Sarcoma, Ewing
5
Lymphoma
5
Breast Neoplasms
5
Spinal Cord Neoplasms
4
Somatostatinoma
4
Neuroectodermal Tumors, Primitive, Peripheral
4
Medulloblastoma
4
Colorectal Neoplasms
4
Small Cell Lung Carcinoma
3
Lung Neoplasms
3
Gastrinoma
3
Carcinoma, Islet Cell
3
Uveal Melanoma
2
Rhabdomyosarcoma
2
Interventions
Radiotherapy
2
Pyridoxine
2
Etoposide
2
Cytarabine
2
Cyclophosphamide
2
sodium thiosulfate
1
pegfilgrastim
1
pegaspargase
1
etoposide phosphate
1
Vincristine
1
Triptorelin Pamoate
1
Rituximab
1
Prednisolone
1
Methylprednisolone
1
Methotrexate
1
Mercaptopurine
1
Leucovorin
1
Hydrocortisone
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Doxorubicin
1
Dexrazoxane
1
Dexamethasone
1
Celecoxib
1
Carboplatin
1
Capecitabine
1
Asparaginase
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Drug-Related Side Effects and Adverse Reactions
×
Temozolomide
×
Clear all
No trials found.